MEDIPOST Email Formats

Biotechnology Research • Cambridge, Massachusetts, United States • 21-50 Employees

MEDIPOST Email Formats

MEDIPOST uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@medi-post.com), used 41.2% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@medi-post.com	64.7%
{first initial}.{last name}	j.doe@medipostamerica.com	11.8%
{first name}{last name}	johndoe@medi-post.com	23.6%

Key Contacts at MEDIPOST

Julian A Bonner

Director, Clinical Programs

Antonio S J Lee

Ceo & Managing Director

Ray Bergeron

Senior Director, Controller

Youngmi Lee

Associate Director, Business Development And Fp&A

Jimin Seo

Process Development, Associate Director

Company overview

Headquarters	245 Main St, Cambridge, Massachusetts 02142, US
Phone number	+13016051087
Websites	medi-post.com medi-post.co.kr medipostamerica.com
NAICS	541714
SIC	873
Employees	21-50
Socials

About MEDIPOST

MEDIPOST, Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases. The company's flagship product, CARTISTEM®, is the world's first allogeneic stem cell therapy, used to treat knee cartilage lesions caused by inflammation, approved in Korea in 2012 and used to treat over 30,000 patients. In the United States, CARTISTEM is entering late-stage development as a potential treatment for cartilage defects associated with knee osteoarthritis. In partnership with the Centre for Commercialization of Regenerative Medicine (CCRM), MEDIPOST has established OmniaBio, a cell and gene therapy contract development and manufacturing organization (CDMO) based in Hamilton, Ontario, to manufacture CARTISTEM.